|
|
|
Home > Product > Product Search |
|
|
|
  Ahngook Lansoprazole tab. |
|
|
|
|
|
|
|
|
|
|
proton pump inhibitor (PPI) |
|
|
|
Short-Term Treatment of Active Duodenal Ulcer,H. pyloriEradication to Reduce the Risk of Duodenal Ul |
|
|
|
Lansoprazole |
|
|
|
|
|
|
|
Ethical the Counter(ETC) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) Composition Lansoprazole-------------30.0mg
2) Indications Short-Term Treatment of Active Duodenal Ulcer Ahngook Lansoprazole tab. is indicated for short-term treatment (for 4 weeks) for healing and symptom relief of active duodenal ulcer.
H. pyloriEradication to Reduce the Risk of Duodenal Ulcer Recurrence
Triple Therapy: Ahngook Lansoprazole tab. /amoxicillin/clarithromycin
Ahngook Lansoprazole tab. in combination with amoxicillin plus clarithromycin as triple therapy is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one-year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Dual Therapy: PREVACID/amoxicillin Ahngook Lansoprazole tab. in combination with amoxicillin as dual therapy is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one-year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Maintenance of Healed Duodenal Ulcers Ahngook Lansoprazole tab. is indicated to maintain healing of duodenal ulcers. Controlled studies do not extend beyond 12 months.
Short-Term Treatment of Active Benign Gastric Ulcer Ahngook Lansoprazole tab. is indicated for short-term treatment (up to 8 weeks) for healing and symptom relief of active benign gastric ulcer.
Healing of NSAID-Associated Gastric Ulcer Ahngook Lansoprazole tab. is indicated for the treatment of NSAID-associated gastric ulcer in patients who continue NSAID use. Controlled studies did not extend beyond 8 weeks.
Risk Reduction of NSAID-Associated Gastric Ulcer Ahngook Lansoprazole tab. is indicated for reducing the risk of NSAID-associated gastric ulcers in patients with a history of a documented gastric ulcer who require the use of an NSAID. Controlled studies did not extend beyond 12 weeks.
Gastroesophageal Reflux Disease (GERD) Short-Term Treatment of Symptomatic GERD Ahngook Lansoprazole tab. is indicated for the treatment of heartburn and other symptoms associated with GERD.
Short-Term Treatment of Erosive Esophagitis Ahngook Lansoprazole tab. is indicated for short-term treatment (up to 8 weeks) for healing and symptom relief of all grades of erosive esophagitis.
For patients who do not heal with Ahngook Lansoprazole tab. for 8 weeks (5-10%), it may be helpful to give an additional 8 weeks of treatment.
If there is a recurrence of erosive esophagitis an additional 8-week course of Ahngook Lansoprazole tab. may be considered.
Maintenance of Healing of Erosive Esophagitis Ahngook Lansoprazole tab. is indicated to maintain healing of erosive esophagitis. Controlled studies did not extend beyond 12 months.
Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome Ahngook Lansoprazole tab. is indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
3)Dosage & Administration Indication Recommended Dose Frequency Duodenal Ulcers Short-Term Treatment 15 mg Once daily for 4 weeks Maintenance of Healed 15 mg Once daily H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence Triple Therapy: Lansoprazole 30 mg Twice daily (q12h) for 10 or 14 days Amoxicillin 1 gram Twice daily (q12h) for 10 or 14 days Clarithromycin 500 mg Twice daily (q12h) for 10 or 14 days Dual Therapy: Lansoprazole 30 mg Three times daily (q8h) for 14 days Amoxicillin 1 gram Three times daily (q8h) for 14 days Benign Gastric Ulcer Short-Term Treatment 30 mg Once daily for up to 8 weeks NSAID-associated Gastric Ulcer Healing 30 mg Once daily for 8 weeks Risk Reduction 15 mg Once daily for up to 12 weeks Gastroesophageal Reflux Disease (GERD) Short-Term Treatment of Symptomatic GERD 15 mg Once daily for up to 8 weeks Short -Term Treatment of Erosive Esophagitis 30 mg Once daily for up to 8 weeks Pediatric (1 to 11 years of age) Short-Term Treatment of Symptomatic GERD and Short-Term Treatment of Erosive Esophagitis ¡Â 30 kg 15 mg Once daily for up to 12 weeks > 30 kg 30 mg Once daily for up to 12 weeks (12 to 17 years of age) Short-Term Treatment of Symptomatic GERD Nonerosive GERD 15 mg Once daily for up to 8 weeks Erosive Esophagitis 30 mg Once daily for up to 8 weeks Maintenance of Healing of Erosive Esophagitis 15 mg Once daily Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome 60 mg Once daily
4)Package
100T
5)Storage
tight container, at room temperature
|
|
|
|
|
|
|